Vaccination With Designed Neopeptides Induces Intratumoral Cross-Reactive CD4+ T-Cell Responses in Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Vaccination with designed neopeptides induces intratumoral, cross-reactive CD4+ T cell responses in glioblastoma
Clin. Cancer Res 2022 Oct 13;[EPub Ahead of Print], J Wang, T Weiss, MC Neidert, NC Toussaint, R Naghavian, C Moreno Sellés, M Foege, P Tomas Ojer, G Medici, I Jelcic, D Schulz, E Rushing, S Dettwiler, B Schrörs, JH Shin, R McKay, CJ Wu, A Lutterotti, M Sospedra, H Moch, EF Greiner, B Bodenmiller, L Regli, M Weller, P Roth, R MartinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.